Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy

The purpose of this study was to determine the dynamic contributions of different immune cell subsets to primary and abscopal tumor regression after hypofractionated radiation therapy (hRT) and the impact of anti-PD-1 therapy. A bilateral syngeneic FSA1 fibrosarcoma model was used in immunocompetent...

Descripción completa

Detalles Bibliográficos
Autores principales: Nesseler, Jean Philippe, Lee, Mi-Heon, Nguyen, Christine, Kalbasi, Anusha, Sayre, James W., Romero, Tahmineh, Nickers, Philippe, McBride, William H., Schaue, Dörthe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140082/
https://www.ncbi.nlm.nih.gov/pubmed/32197352
http://dx.doi.org/10.3390/cancers12030714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140082/
https://www.ncbi.nlm.nih.gov/pubmed/32197352
http://dx.doi.org/10.3390/cancers12030714

Ejemplares similares